Clinical Trial Update: Chemoembolization of the Liver With or Without Sunitinib Malate in Treating Patients With Liver Cancer [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial evaluating chemoembolization of the liver with or without sunitinib malate for liver cancer has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Cancer

Drugs mentioned

• Sunitinib malate (sunitinib malate)

Snippet

Sponsor: Federation Francophone de Cancerologie Digestive | Conditions: Liver Cancer | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2022-03-18